127 related articles for article (PubMed ID: 30054487)
1. ARD1/NAA10 acetylation in prostate cancer.
Kuhns KJ; Zhang G; Wang Z; Liu W
Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
[TBL] [Abstract][Full Text] [Related]
2.
Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
Elife; 2021 Aug; 10():. PubMed ID: 34355692
[TBL] [Abstract][Full Text] [Related]
3. Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects.
Ho KH; Pan KF; Cheng TY; Chien MH; Hua KT
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188973. PubMed ID: 37659460
[TBL] [Abstract][Full Text] [Related]
4. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
[TBL] [Abstract][Full Text] [Related]
6. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
[TBL] [Abstract][Full Text] [Related]
7. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis.
Ding Y; Chi H; Shao J; Shi T; Yu H; Wang X; Wang X
Clin Transl Med; 2022 Feb; 12(2):e676. PubMed ID: 35172032
[TBL] [Abstract][Full Text] [Related]
9. The role of N-acetyltransferases in cancers.
Zhu R; Chen M; Luo Y; Cheng H; Zhao Z; Zhang M
Gene; 2024 Jan; 892():147866. PubMed ID: 37783298
[TBL] [Abstract][Full Text] [Related]
10. Post-Translational Modifications That Drive Prostate Cancer Progression.
Samaržija I
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572160
[TBL] [Abstract][Full Text] [Related]
11. The mechanistic role of NAT10 in cancer: Unraveling the enigmatic web of oncogenic signaling.
Rodrigues P; Bangali H; Ali E; Nauryzbaevish AS; Hjazi A; Fenjan MN; Alawadi A; Alsaalamy A; Alasheqi MQ; Mustafa YF
Pathol Res Pract; 2024 Jan; 253():154990. PubMed ID: 38056132
[TBL] [Abstract][Full Text] [Related]
12. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
Lyon GJ; Vedaie M; Beisheim T; Park A; Marchi E; Gottlieb L; Hsieh TC; Klinkhammer H; Sandomirsky K; Cheng H; Starr LJ; Preddy I; Tseng M; Li Q; Hu Y; Wang K; Carvalho A; Martinez F; Caro-Llopis A; Gavin M; Amble K; Krawitz P; Marmorstein R; Herr-Israel E
Eur J Hum Genet; 2023 Jul; 31(7):824-833. PubMed ID: 37130971
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
Hum Mol Genet; 2020 Mar; 29(5):877-878. PubMed ID: 32027362
[No Abstract] [Full Text] [Related]
14. Diverse roles of arrest defective 1 in cancer development.
Chaudhary P; Ha E; Vo TTL; Seo JH
Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105
[TBL] [Abstract][Full Text] [Related]
15. Evaluating possible maternal effect lethality and genetic background effects in
Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
bioRxiv; 2024 Jan; ():. PubMed ID: 37163119
[TBL] [Abstract][Full Text] [Related]
16. N-α-Acetyltransferase 10 inhibits invasion and metastasis of oral squamous cell carcinoma via regulating Pirh2-p53 signalling pathway.
Wang F; Zheng J; Yang J; Luo T; Xu J; Yang Y; Gu Y; Zeng Y
J Cell Mol Med; 2022 May; 26(10):2921-2934. PubMed ID: 35366056
[TBL] [Abstract][Full Text] [Related]
17. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of Ogden syndrome as an X-linked recessive fatal disorder due to a recurrent NAA10 variant and review of the literature.
Gogoll L; Steindl K; Joset P; Zweier M; Baumer A; Gerth-Kahlert C; Tutschek B; Rauch A
Am J Med Genet A; 2021 Aug; 185(8):2546-2560. PubMed ID: 34075687
[TBL] [Abstract][Full Text] [Related]
19.
McTiernan N; Darbakk C; Ree R; Arnesen T
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
